58
Participants
Start Date
April 30, 2019
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2023
Axitinib
"Avelumab 10 mg/kg will be administered every two weeks. Avelumab is administered as a 1-hour iv infusion, diluted with 0.9% saline solution; Axitinib 5 mg should be taken orally twice daily approximately 12 hours apart with or without food. They should be swallowed whole with a glass of water. If the patient vomits or misses a dose, an additional dose should not be taken. The next prescribed dose should be taken at the usual time.~The duration of treatment cycle is 28 days."
Maria Sklodowska-Curie National Research Institue of Oncology, Warsaw
Maria Sklodowska-Curie National Research Institute of Oncology
OTHER